361 results on '"Ahmad, Nadia"'
Search Results
2. Medical Treatment of Obesity
3. Sublethal impacts of Buprofezin and Pyriproxyfen on cotton mealybug Phenacoccus solenopsis through transgenerational hormesis
4. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
5. Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
6. Improved Transdermal Delivery of Rabies Vaccine using Iontophoresis Coupled Microneedle Approach
7. General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial
8. A qualitative study to examine meaningful change in physical function associated with weight-loss
9. Weight-Reduction Preferences Among OBSERVE Study Participants With Obesity or Overweight: Opportunities for Shared Decision-Making
10. Engineering of tetanus toxoid-loaded polymeric microneedle patches
11. Weight management treatment modalities in patients with overweight or obesity: A retrospective cohort study of administrative claims data
12. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
13. Abstract 15280: Does Weight Reduction Drive the Reduction in Blood Pressure in People Living With Obesity Treated With Tirzepatide?: Insights From SURMOUNT-1 Study
14. Legalizing Humanitarian Intervention in Response to Chemical Weapon Usage : Syrian Conflict’s Impact on International Law
15. #1704946 Improvements in Physical Functioning Among Participants With Obesity With Limitations in Physical Function at Baseline: Results from SURMOUNT-1 and SURMOUNT-2 Trials
16. Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m 2 : SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy
17. THE CLIODYNAMICS OF MASS INCARCERATION, CLIMATE CHANGE, AND 'CHAINS ON OUR FEET'
18. The Health Effects of Obesity
19. Transnational Energy Law Regimes and Systems Dynamics
20. Estimation of Heterosis and Combining Ability for Yield and Fibre Related Traits in Gossypium hirsutum L.
21. Abstract 10370: Effects of Tirzepatide on 24-Hour Ambulatory Blood Pressure and Heart Rate in Adults With Obesity - Results From the SURMOUNT-1 Ambulatory Blood Pressure Monitoring Sub-Study
22. Addressing the failures of undergraduate anatomy education: Dissecting the issue and innovating a solution
23. MILITARY CLIMATE EMISSIONS.
24. Clinical, economic, and health‐related quality of life outcomes in patients with overweight or obesity in the United States: 2016–2018
25. Stratification of obesity phenotypes to optimize future therapy (SOPHIA)
26. SAT660 Predictors Of Achieving Body Weight Reduction ≥20% With Tirzepatide In People With Overweight Or Obesity In SURMOUNT-1
27. Real-world primary nonadherence to antiobesity medications
28. SAT658 Tirzepatide Reduces The Predicted Risk Of Developing Atherosclerotic Cardiovascular Disease: A Post-hoc Analysis Of The Surmount-1 Trial
29. Contributors
30. Machine learning in translational bioinformatics
31. Financial Incentives for Wetland Protection and Restoration
32. Clinical, economic, and health‐related quality of life outcomes in patients with overweight or obesity in the United States: 2016–2018.
33. EXIST: EXamining rIsk of excesS adiposiTy—Machine learning to predict obesity‐related complications.
34. Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT‐1 post hoc analysis.
35. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.
36. Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT‐1 trial
37. EXIST: EXamining rIsk of excesS adiposiTy – Machine Learning to Predict Obesity‐Related Complications
38. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
39. RESPONSIVE REGULATION AND RESILIENCY : THE RENEWABLE FUEL STANDARD AND ADVANCED BIOFUELS
40. LETTERS TO THE EDITOR
41. A formal synthesis of garsubellin A via bridgehead substitution
42. Abstract #1495502: Healthcare Providers' Perceptions of Anti-obesity Medications: Results from the OBSERVE Study
43. Variation in Anatomical Position of Vermiform Appendix
44. Tirzepatide reduces body weight across body mass index (BMI) categories: A SURMOUNT-1 pre-specified analysis
45. ABA at COP28: Calling on the legal community for a common cause.
46. TO DETERMINE THE DIAGNOSTIC ACCURACY OF ULTRASONOGRAPHY IN DETECTING CHOLEDOCHOLITHIASIS IN PATIENTS OF OBSTRUCTIVE JAUNDICE KEEPING MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY AS GOLD STANDARD.
47. Study of Morphometric Analysis of Acetabulum and its Clinical Correlation
48. Sublethal impacts of Buprofezin and Pyriproxyfen on cotton mealybug Phenacoccus solenopsis through transgenerational hormesis
49. Role of vermal anteroposterior length and width in age determination of fetus
50. Military Carbon Emissions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.